Broadridge Financial Solutions, Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 8, 2024 and accepted by EDGAR at May 8, 2024, 10:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $1.73bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $4.56bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $1.19bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $3.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $236.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-07-01 to 2024-03-31 | $667.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $302.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | $575.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $52.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $92.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $213.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | $374.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $1.79 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | $3.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $1.81 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | $3.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 119,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 119,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | $335.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $39.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-07-01 to 2024-03-31 | $273.9m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2023-07-01 to 2024-03-31 | $161.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $235.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $1.57bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $8.22bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $1.12bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $5.95bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $3.51bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $0 | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-03-31 | $2.27bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001383312-24-000028. Last ingested by Listed: Nov 12, 2026, 23:52 ET. Listed shows no prices and gives no investment advice.